EDGAR Filing Documents for 0001193125-12-489357

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001193125-12-489357

Filing Date

2012-12-03

Accepted

2012-12-03 17:22:02

Documents

Period of Report

2012-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO FORM 20-F	d447397d20fa.htm	20-F/A	73446
2	COOPERATION AGREEMENT	d447397dex45.htm	EX-4.5	65477
3	CERTIFICATION OF CHIEF EXECUTIVE OFFICER AS REQUIRED BY RULE 13A-14(A)	d447397dex121.htm	EX-12.1	2281
4	CERTIFICATION OF CHIEF FINANCIAL OFFICER AS REQUIRED BY RULE 13A-14(A)	d447397dex122.htm	EX-12.2	2318
5	GRAPHIC	g447397g10t86.jpg	GRAPHIC	4318
6	GRAPHIC	g447397g84i27.jpg	GRAPHIC	798
	Complete submission text file	0001193125-12-489357.txt		151830

Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000

Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224

IRS No.: 000000000
Type: 20-F/A | Act: 34 | File No.: 001-35428 | Film No.: 121238374
SIC: 2834 Pharmaceutical Preparations